Dave Stevenson - Managing Director @ Merck Global Health Innovation Fund

Overview

CB Rank (Investor)

Dave Stevenson is and investment principle responsible for identifying investment opportunities in emerging healthcare solutions and services.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Ayogo Health	Merck Global Health Innovation Fund	—	Series B - Ayogo Health	obfuscated obfuscation
obfuscated obfuscation	Ayogo Health	Merck Global Health Innovation Fund	Yes	Series A - Ayogo Health	obfuscated obfuscation

Number of Current Jobs

is the

Managing Director

Hub Name	CB Rank (Hub)
Corporate VC Investors with Investments in United States	18,676
Corporate VC Investors	12,235
Corporate VC Investors with Investments in Great Lakes	43,446
Private Equity Stage Investors Corporate VC Investors	57,571
Northeastern US Corporate VC Investors	64,493
Johnson & Johnson Alumni Founded Companies	73,093
Early Stage Venture Investors with Investments in Great Lakes	3,516
United States Corporate VC Investors	30,031
Private Equity Stage Investors with Investments in Great Lakes	12,037
Early Stage Venture Investors Corporate VC Investors	11,193

studied at

and

There is no recent news or activity for this profile.